Method for treating cancer using A33 specific antibodies and chemotherapeutic agents
US6652853B2 · kind B2 · utility
17Cited by
1References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 8, 2001 |
| Grant date | Nov 25, 2003 |
| Priority date | — |
| Expiry date | Aug 3, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a combination of immunotherapy and chemotherapy to promote tumor regression by treating a patient in need thereof with a combination of a humanized antibody that binds to A33 antigen and one or more chemotherapeutic agents. The method is useful for treating patients with colorectal cancer and gastric carcinomas. The method is particularly useful for treating patients who have tumors that are resistant to one or more chemotherapeutic agents and/or have metastasized.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.